Charantin
A group of plant compounds unique to bitter melon that have traditionally been used to support healthy blood sugar, though modern human trial results are inconsistent.
Also known as Momordica charantia glycosides
What it does
Traditional blood-glucose-support compound
Charantin is a mixture of steroidal saponins/glycosides found in bitter melon (Momordica charantia), often discussed alongside related compounds such as momordicin and a plant polypeptide (polypeptide-p). Laboratory and animal studies suggest these compounds may influence glucose uptake and pancreatic beta-cell activity, but this has not translated consistently into human clinical outcomes.
Pathways it supports
These are the ways this compound is linked to the body, strongest link first.
- Reduces Post-Meal Glucose ResponseHelps reduce the blood sugar spike after eating.Modest link
- Supports Glucose UptakeHelps cells take up glucose from the blood for energy.Modest link
- Supports Insulin SensitivitySupports how well the body's cells respond to insulin.Modest link
Foods that contain it
1 foods are linked to Charantin. These 1 are the best sources in the data.
- Bitter Melon (Bitter Gourd) (opens in a new tab)VegetablesModest
The bar shows how good a source each food is in the curated data. Amounts vary with the variety, growing conditions and how the food is prepared.
Evidence and sources
Research strength: Low. The rating draws on Harvard T.H. Chan School of Public Health.
What the sources are: 3 sources studied people (2 meta-analyses, 1 systematic review); 1 is a background review that explains the science; 1 other source.
- The metabolic effect of Momordica charantia cannot be determined based on the available clinical evidence: a systematic review and meta-analysis of randomized clinical trials (opens in a new tab)Frontiers in Nutrition, 2024Meta-analysisDOI (opens in a new tab)
- The effects of bitter melon (Momordica charantia) on anthropometric indices in adults: A systematic review and meta-analysis of randomized controlled trials (opens in a new tab)Prostaglandins & other lipid mediators, 2024Meta-analysisDOI (opens in a new tab)
- Momordica charantia L. lowers elevated glycaemia in type 2 diabetes mellitus patients: Systematic review and meta-analysis (opens in a new tab)Journal of ethnopharmacology, 2019Meta-analysisDOI (opens in a new tab)
- Momordica charantia for type 2 diabetes mellitus (opens in a new tab)The Cochrane database of systematic reviews, 2012Systematic reviewDOI (opens in a new tab)
- Pharmacotherapeutic Potential of Bitter Gourd (Momordica charantia) in Age-related Neurological Diseases (opens in a new tab)Journal of integrative neuroscience, 2024Review articleDOI (opens in a new tab)
Source links last checked on 1 November 2026.
This page is general information about food and wellbeing. It is not medical advice and does not replace advice from your doctor or dietitian.